ClearPoint Neuro’s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Technology applications include deep-brain stimulation, laser catheters, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene and stem cell therapies to the brain. The ClearPoint® Neuro Navigation System is FDA cleared, CE-marked, and installed in 60 active clinical sites in the United States. The Company’s SmartFlow® Cannula is being used in partnership with 20+ individual biologics and drug delivery companies from preclinical research to late stage regulatory trials in the U.S., EU and Asia. To date, more than 3,600 cases have been performed and supported by the Company’s field-based clinical specialist team which offers support and services for our partners.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commericalization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on Twitter at @PTCBio, and on LinkedIn.